Definium Therapeutics Inc. Common Shares vs Knight-Swift Transportation Holdings Inc. — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Knight-Swift Transportation Holdings Inc. trades at $65.05 (market cap $10.35B). The key difference: Knight-Swift Transportation Holdings Inc. is far larger — about 2.2× Definium Therapeutics Inc. Common Shares's market cap, and Knight-Swift Transportation Holdings Inc. pays a 1.26% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Knight-Swift Transportation Holdings Inc. for 0 Days on average.
| DFTX | KNX | |
|---|---|---|
Market Cap | $4.71B | $10.35B |
Volume | 1,966,636 | 2,161,869 |
Sector | Health | Industrials |
52-Week High | $48.45 | $82.45 |
52-Week Low | $10.68 | $41.68 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $12.85B |
Dividend Yield | — | 1.26% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Knight-Swift provides truckload, less-than-truckload, logistics, and freight management services. It operates a large transportation network across North America.
Read more on KNX →